載入中
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
前收盤價
US$5.25
−US$0.02 · -0.38%
盤中時間採用ET。市場資料可能有所延遲。
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
日內區間
目前US$5.25
52週區間
目前US$5.25
盤中時間採用ET。市場資料可能有所延遲。
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
日內區間
目前US$5.25
52週區間
目前US$5.25
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 銷貨成本 | — | 26.74萬 USD | — | 14.78萬 USD | 5.94萬 USD |
| 毛利 | — | −26.74萬 USD | — | −14.78萬 USD | −5.94萬 USD |
| 研究與開發 | 370.7萬 USD | 186.88萬 USD | 52.75萬 USD | 34.81萬 USD | 45.45萬 USD |
| 銷售、一般及管理費用 | 591.35萬 USD | 379.6萬 USD | 133.88萬 USD | 83.68萬 USD | 77.9萬 USD |
| 營業費用 | 971.65萬 USD | 566.47萬 USD | 179.62萬 USD | 118.49萬 USD | 123.34萬 USD |
| 利息收入 | — | 7.76萬 USD | 100 USD | 98 USD | — |
| 折舊和攤銷 | 28.8萬 USD | 26.74萬 USD | 19.69萬 USD | 14.78萬 USD | 5.94萬 USD |
| 營業利益 | −971.65萬 USD | −593.21萬 USD | −179.62萬 USD | −133.27萬 USD | −129.28萬 USD |
| 淨利 | −915.87萬 USD | −586.13萬 USD | −203.84萬 USD | −139.61萬 USD | −120.91萬 USD |
公司資料更新於 2026年10月11日。
近期已公布業績
報告持有此股票曝險的交易所交易基金。
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
